About
Nanotherm Therapeutics is a medical device manufacturer redefining solid tumor treatment. The team has expertise and experience in cancer ablation, clinical development, commercial, and regulatory.
Management
Andreas Jordan
CEO & Founder
Jan-Marc Lieskovsky
CBO
Gernot Sklenofsky
CFO
Board
Tom Miller
Founder at GreyBird Ventures, Former Global CEO roles at Siemens, Carl Zeiss, Analogic
Euan S. Thomson
CEO Carl Zeiss Meditec Inc, Former CEO Accuray, Global Head of R&D at J&J
Clinical Steering Committee
Erik Folch, MD
Co-Director, Interventional Pulmonology at MGH Prof at Havard Medical
Nanotherm Therapeutics in numbers
Demonstrated progress in developing and delivering advanced oncological therapies.
200+
Patients with over 1000 activations treated with NTTS
+25
Years of research, development, and clinical progress demonstrating long-term toxicology and stability.
03
Clinical centers conducting research
100
Patents – Strong intellectual property across key global markets
QMS
Quality Management System is ISO 13485:2016 conformal. Previously: MDR certified.